Dr. Kröger is a research scientist at the Centre d’excellence sur le vieillissement de Québec (CEVQ) du CIUSSSCN and an adjunct professor at the Faculté de pharmacie de l’Université Laval and at the Department of Family Medicine of McGill University. A pharmacist and (pharmaco-) epidemiologist by training, Dr Kröger uses data from epidemiological cohort studies or from administrative data banks for her research. She also performs systematic, scoping or mixed methods knowledge syntheses. For over 10 years, she has been studying risk factors for dementia (Interview with the Australian Broadcasting Corporation, Seafood: mercury and dementia, http://www.abc.net.au/radionational/programs/(healthreport/seafood,-mercury,-and-dementia./7149328, ABC).
Dr. Kröger’s current research program focuses on the medication treatment of seniors affected by dementia. It aims at improving medication use and, more specifically, deprescribing medications of questionable benefit (http://pourvivreensante.com/est-ce-que-je-prends-trop-de-medicaments/). Since 2013, she has been leading intervention and evaluation studies in long-term care facilities to assess whether interdisciplinary knowledge exchange interventions, together with critical medication reviews based on validated criteria, are successful in deprescribing medications of questionable benefit and to decrease residents’ medication load.(« OptimaMed » and « PEPS » studies http://www.ciusss-capitalenationale.gouv.qc.ca/sites/default/files/medication_demence_severe_oct2015.pdf).
Furthermore, Dr. Kröger is an affiliated researcher at the Institut national de santé publique du Québec (INSPQ) where she collaborates in the surveillance of dementia and related diseases in the Quebec population (https://www.inspq.qc.ca/es/node/4223).She is also a member of the Scientific Council of the Institut national d’excellence en santé et en services sociaux (INESSS) and a scientist member of the Ethics Research Board of the CIUSSSCN.
1050, chemin Sainte-Foy
L2-30
Québec, Québec
Canada G1S 4L8
Latest news
Data not available
- Poisblaud, LiseEmployeeHôpital Saint-Sacrementlise.poisblaud@crchudequebec.ulaval.ca
1050 Chemin Sainte-Foy
Québec, QC
Canada G1S 4L8
A New Care Model Reduces Polypharmacy and Potentially Inappropriate Medications in Long-Term Care.
Journal ArticleJ Am Med Dir Assoc, 22 (1), pp. 141-147, 2021, ISSN: 1525-8610.
Professional training on shared decision making with older adults living with neurocognitive disorders: a mixed-methods implementation study.
Journal ArticleBMC Med Inform Decis Mak, 20 (1), pp. 189, 2020.
Is Benzodiazepine Use Associated With the Risk of Dementia and Cognitive Impairment-Not Dementia in Older Persons? The Canadian Study of Health and Aging.
Journal ArticleAnn Pharmacother, 54 (3), pp. 219-225, 2020, ISSN: 1060-0280.
Polypharmacy Definitions for Multimorbid Older Adults Need Stronger Foundations to Guide Research, Clinical Practice and Public Health.
Journal ArticlePharmacy (Basel), 7 (3), 2019, ISSN: 2226-4787.
Exposure to polychlorinated biphenyls and organochlorine pesticides and risk of dementia, Alzheimer's disease and cognitive decline in an older population: a prospective analysis from the Canadian Study of Health and Aging.
Journal ArticleEnviron Health, 18 (1), pp. 57, 2019.
Reducing complexity of patient decision aids for community-based older adults with dementia and their caregivers: multiple case study of Decision Boxes.
Journal ArticleBMJ Open, 9 (5), pp. e027727, 2019.
Is the Drug Burden Index Related to Declining Functional Status at Follow-up in Community-Dwelling Seniors Consulting for Minor Injuries? Results from the Canadian Emergency Team Initiative Cohort Study.
Journal ArticleDrugs Aging, 36 (1), pp. 73-83, 2019, ISSN: 1170-229X.
The OptimaMed intervention to reduce inappropriate medications in nursing home residents with severe dementia: results from a quasi-experimental feasibility pilot study.
Journal ArticleBMC Geriatr, 18 (1), pp. 204, 2018.
Tailoring and evaluating an intervention to improve shared decision-making among seniors with dementia, their caregivers, and healthcare providers: study protocol for a randomized controlled trial.
Journal ArticleTrials, 19 (1), pp. 332, 2018.
Caring for seniors living with dementia means caring for their caregivers too.
Journal ArticleCan J Public Health, 108 (5-6), pp. e639-e642, 2018, ISSN: 0008-4263.
Active projects
- Centre de recherche du CHU de Québec - Université Laval, Subvention, Centre hospitalier universitaire de Québec - Université Laval, Centres de recherche affiliés, from 2017-01-01 to 2099-12-31
- Development and initial validation of measures of cancer pain under- and overtreatment, Subvention, Fonds de recherche du Québec - Santé, Réseaux thématiques de recherche, from 2020-04-01 to 2021-03-31
- Phase Two of the Canadian Consortium on Neurodegeneration in Aging, Subvention, Instituts de recherche en santé du Canada, Consortium canadien en neurodégénérescence et vieillissement (CCNV), from 2019-04-01 to 2024-03-31
- Projet de recherche sur les modèles novateurs de milieu de vie des aînés atteints de problèmes cognitifs : similitudes, différences, forces et défis, Subvention, Ministère de la Santé et des Services sociaux, from 2019-04-01 to 2023-03-31
- Projet GPS: Évaluation de l'impact de la réorganisation du travail en Groupe de médecine de famille (GMF) sur la Pharmacothérapie et le Soutien à l'autonomie des personnes âgées ayant un trouble neuro-cognitif majeur, Subvention, Fonds de recherche du Québec - Santé, Plateforme de financements de la recherche intersectorielle sur le vieillissement - Living Lab, from 2019-04-01 to 2022-06-30
- VITAM – Centre de recherche en santé durable, Subvention, CIUSSS - CN - VITAM, Centres de recherche affiliés, from 2017-01-01 to 2099-12-31
Recently finished projects
- Deprescribing inappropriate medication in residents suffering from severe dementia: OptimaMed long term care, a demonstration project, Subvention, Société Alzheimer du Canada, Subventions de recherche, from 2016-09-01 to 2019-08-31
- Le cannabis médical contre les douleurs musculo-squelettiques chroniques : une étude de l'usage parmi des personnes âgées de 60 ans et plus au Québec et au Canada, Subvention, Fonds de recherche du Québec - Santé, Réseaux thématiques de recherche, from 2018-04-01 to 2020-03-31
- Le cannabis médical contre les douleurs musculosquelettiques chroniques: une étude aux méthodes mixtes sur les déterminants de l'usage parmi des patients et des médecins canadiens, Subvention, Instituts de recherche en santé du Canada, Programme de subvention Catalyseur, from 2019-03-01 to 2020-02-29
- Medical cannabis against chronic musculoskeletal pain - a mixed methods study to describe use and to identify its facilitors and barriers among Canadian patients and doctors, Subvention, Instituts de recherche en santé du Canada, Subvention Projet, from 2019-03-01 to 2020-02-29
- Projet d'évaluation de la personnalisation des soins pharmaceutiques (PEPS) en centre d'hébergement de soins de longue durée (CHSLD), Subvention, Ministère de la Santé et des Services sociaux, from 2018-05-11 to 2019-06-30